Moyamoya Disease management strategies in adults
Moyamoya disease is a rare, progressive cerebrovascular disorder characterized by the narrowing of the internal carotid arteries and their main branches at the base of the brain. As a result, abnormal vascular networks develop to compensate for reduced blood flow, creating a distinctive “puff of smoke” appearance on angiograms. While often diagnosed in children, adults can also be affected, and management strategies for adult patients require nuanced approaches that address both the disease’s progression and the unique clinical presentations.
In adults, moyamoya disease frequently presents with ischemic strokes, transient ischemic attacks (TIAs), or hemorrhagic strokes due to the fragile collateral vessels. Symptom management begins with a thorough clinical assessment, including neuroimaging techniques such as magnetic resonance angiography (MRA) or digital subtraction angiography (DSA), which are critical for confirming the diagnosis and assessing the extent of arterial occlusion. Accurate imaging guides treatment planning and helps differentiate moyamoya from other vasculopathies.
Medical management plays a vital role in stabilizing symptoms and preventing stroke recurrence. Antiplatelet agents, like aspirin, are commonly prescribed to reduce the risk of thrombotic events, especially in patients with ischemic presentations. Blood pressure control is equally essential, as hypertension can exacerbate hemorrhagic risk. However, medication alone rarely halts disease progression; it primarily serves as a supportive measure or interim therapy while definitive surgical options are evaluated.
Revascularization surgery remains the cornerstone of moyamoya management in adults. The goal is to restore or improve cerebral blood flow, diminish the risk of future ischemic or hemorrhagic strokes, and alleviate symptoms. There are two main surgical approaches: direct bypass and indirect revascularization. Direct bypass involves connecting a scalp artery, such as the superficial temporal artery, directly to an intracranial artery, creating a new pathway for blood flow. Indirect methods, like encephaloduroarteriosynangiosis (EDAS) or encephalomyosynangiosis (EMS), encourage the development of new collateral vessels over time by placing vascularized tissue in contact with the brain surface.
In adults, direct bypass is often favored due to its more immediate improvement in cerebral perfusion. Nonetheless, the choice of procedure depends on individual anatomy, surgical expertise, and the patient’s overall health status. Postoperative management includes close monitoring for complications such as hyperperfusion syndrome, which can cause hemorrhage or cerebral edema. Regular follow-up with neuroimaging is crucial to evaluate graft patency and cerebral blood flow, ensuring the success of revascularization.
Preventive strategies extend beyond surgery. Lifestyle modifications, including smoking cessation and managing comorbid conditions like hypertension and diabetes, contribute to reducing cerebrovascular risk. Rehabilitation therapies may be necessary for patients who have experienced strokes, focusing on restoring neurological functions and improving quality of life.
Overall, managing moyamoya disease in adults demands a multidisciplinary approach involving neurologists, neurosurgeons, radiologists, and rehabilitation specialists. Early diagnosis, appropriate medical therapy, timely surgical intervention, and diligent follow-up are essential components to improve outcomes and minimize the risk of catastrophic cerebrovascular events.